Residency training and clinical and research fellowships at Stanford in Retina, Glaucoma, Cornea, Oculoplastics, Pediatrics and Neuro-Ophthalmology, as well as special fellowships in international health and ophthalmic innovation, together offer exciting opportunities to advance the field and develop careers.
Jeffrey L. Goldberg, M.D., Ph.D.
Professor and Chairman
Department of Ophthalmology
Welcome to the Byers Eye Institute in the Department of Ophthalmology, at Stanford University School of Medicine, a top-tier, internationally recognized, multidisciplinary center combining world-class resources with a commitment to providing the highest level of diagnostic and therapeutic care to our patients.
Through an integrated, personalized approach to healthcare delivery, our dedicated team provides the latest therapies in treating eye disorders. Associated with Stanford Health Care, and the Lucille-Packard Children's Hospital, our
Whether you are a patient, a resident, or a leader in academic or clinical ophthalmology, I invite you to explore our programs, visit our clinics and operating rooms, and receive your eye care from our premier faculty.
faculty and staff provide excellence in ocular and vision healthcare to patients across Northern California and from around the world, while our cutting-edge team of researchers carries out some of the most innovative laboratory research and clinical trials anywhere.
We are here for you.
We are searching for the best clinicians, clinician-scientists, and vision research scientists to join our faculty at Stanford. If you are looking for staff positions in administration or laboratory or clinical research, please follow this link.
In the News
There are different ways to occupy your free time during COVID-19 stay home orders, but you should exercise extra caution before considering your next at-home do-it-yourself (DIY) project.
A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.
The Inaugural Optic Disc Drusen Virtual Conference will take place May 11, 2020 at Stanford via Zoom.
Applications are now open and due no later than June 30, 2020 to be considered for the 2021-2022 academic year program.
Please prepare a CV and 1-page personal statement that includes goals for the year and career following the fellowship, and/or any questions via email to the Ophthalmic Innovation Program Fellowship, c/o Katie Majchrzak: email@example.com.
Congratulations to these four faculty for being selected for The Ophthalmologist's Power List 2020, which celebrates the top 100 "most influential figures in ophthalmology"!
University and health system leaders are working closely with government and public health agencies and continue to follow guidelines from the U.S. Department of State, the Centers for Disease Control and Prevention, and the World Health Organization.
Optic disc drusen (ODD) are calcified deposits found at the anterior optic nerve in about 2% of the general population. It affects both children and adults and can sometimes run in families.
The Albion Walter Hewlett Award is a Department of Medicine-sponsored award honoring an exceptional physician with ties to Stanford.
CHICAGO — Researchers used a direct-to-consumer genetic testing service to identify patients with CFH Y402H and ARMS2 A69S alleles, the genetic variants most commonly associated with an increased risk for developing age-related macular degeneration, a speaker said here.
The Stanford Department of Ophthalmology has a rich history of innovation and academic accomplishment dating back more than 100 years.
Almost four years ago, Peggy Kixmoeller was diagnosed with thyroid eye disease (TED). This is an autoimmune disorder where the body mistakenly attacks healthy cells, specifically the thyroid gland and the tissues around the eye.
To a passerby, Cru Silva looks like your average three-year-old. His energy is contagious as he runs around the room laughing and playing with his new toy garbage truck.
About 1.3 billion people worldwide live with some form of visual impairment, 80 percent of which could have been prevented or is treatable, according to the World Health Organization.
Photo courtesy of Ace Kvale and the Himalayan Cataract Project
The Department of Ophthalmology at Stanford prides itself on training undergraduates, medical students, residents, and clinical fellows in both clinical care and innovative research.
Retinal cell death due to glaucoma, diabetic retinopathy, macular degeneration, and a myriad of other conditions leads to irreversible vision loss.
A significant challenge for ophthalmologists is diagnosing diseases that appear clinically similar. Inside the eye, a “snowstorm” of white cells can be due to an autoimmune disease, cancer, or an infection, each requiring very different therapies.
Too many major eye diseases lead to loss of vision that, even with current medicine or surgery, is irreversible. In macular degeneration, glaucoma, and the major corneal diseases, the cells responsible for normal visual function die and are not replaced through natural healing mechanisms.
Luciano Custo Greig, MD, PhD, a current trainee in the Stanford Ophthalmology Advanced Research (SOAR) Residency Program, is the recipient of a Career Starter Grant from the Knights Templar Eye Foundation for his research on regeneration of retinal ganglion cells from endogenous progenitors.
Philanthropic gift creates center to help accelerate translational research, recruit faculty and train the next generation of leaders in vision science.
The recent issue of Stanford Medicine magazine, a theme issue on eyes and vision, includes details about projects and others pushing the boundaries of biology and technology to help people see. Click here to learn more
Illustration by John Hersey